Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
focustechnologies.com

See what CB Insights has to offer

Founded Year

1978

Stage

Acquired | Acquired

Total Raised

$76.59M

Valuation

$0000 

Revenue

$0000 

About Focus Diagnostics

Focus Diagnostics develops diagnostic and database services and products for infectious and immunological diseases.On July 14th, 2006, Focus Diagnostics was acquired by Quest Diagnostics at a valuation of $185M.

Focus Diagnostics Headquarter Location

5785 Corporate Avenue

Cypress, California, 90630,

United States

714-220-1900

Latest Focus Diagnostics News

DiaSorin Completes Acquistion of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics

Dec 29, 2020

Saluggia (Italy) - May 13, 2016 – DiaSorin S.p.A. (FTSE Italy: DIA) today announced the completion of the transaction to acquire the Focus Diagnostics’ immunodiagnostic and molecular diagnostic products business (“Focus”) from Quest Diagnostics (NYSE: DGX), initiated with a binding purchase agreement signed on March 29, 2016. DiaSorin paid to Quest Diagnostics $300 million in cash for all the tangible and intangible assets of Focus used by the latter to develop, manufacture and distribute its molecular diagnostic products and its traditional immunoassay ELISA products, including among other relevant intellectual property, contracts and customer list. Focus’ product lines include the Simplexa™ molecular product line, HerpeSelect® HSV serology, and a line of DxSelect™ IFA and ELISA assays that will continue to be manufactured by the relevant facility in Cypress, California, USA. The transaction does not include Quest Diagnostics’ diagnostic information services laboratories currently operating under the Focus Diagnostics brand. The transaction’s main terms and conditions are those already made available by both parties to the public on March 30, 2016. Wendy Bost (Media) 973-520-2800 (US)   About DiaSorin: Headquartered in Italy and listed in the FTSE Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets which identify DiaSorin Group as the IVD “diagnostics specialist”. www.diasorin.com About Quest Diagnostics: Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Focus Diagnostics Patents

Focus Diagnostics has filed 9 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/29/2014

8/29/2017

Molecular biology, Virology, Transcription factors, Biotechnology, Molecular biology techniques

Grant

Application Date

4/29/2014

Grant Date

8/29/2017

Title

Related Topics

Molecular biology, Virology, Transcription factors, Biotechnology, Molecular biology techniques

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.